Urothelial tumors were found to have a high mutational burden and to express high levels of programmed cell death ligand 1 (PD-L1), which when bound to its PD-1 receptor results in suppression of the T-cell-mediated antitumor immune response allowing immune escape and tumor progression [7]. This evidence concerns the gene CD274 and neoplasm.